Growing demand for antinuclear antibody test, increasing cases of autoimmune diseases across the globe is predicted to be the major driving factor for the global market, contributing to the antinuclear antibody test market growth in the upcoming years.
According to a new report published by Allied Market Research, titled, “Antinuclear Antibody Test Market,” The antinuclear antibody test market size was valued at $1.3 billion in 2021, and is estimated to reach $5 billion by 2031, growing at a CAGR of 15% from 2022 to 2031.
Download Report: https://www.alliedmarketresearch.com/request-sample/4259
Determinants of growth-
Increasing prevalence of autoimmune diseases among people drives the growth of the global antinuclear antibody test market. Moreover, the fact that antinuclear antibody tests are becoming more and more popular as a way to diagnose autoimmune diseases such as rheumatoid arthritis, Systemic Lupus Erythematosus, Sjogren’s Syndrome, and others has supplemented the growth even more. Moreover, growing government healthcare insurance and rising awareness about autoimmune disorders are expected to create lucrative opportunities in the industry.
Rapidly increasing autoimmune disease incidences among people, across the globe, is expected to be the main factor driving the global antinuclear autoimmune test market. Additionally, the majority of people have health insurance due to their rising health related awareness through government campaigns. This factor is predicted to accelerate the expansion of the market for antinuclear antibodies throughout the projected period. These factors are anticipated to propel the antinuclear antibody test market growth.
Covid-19 scenario-
- The outbreak of the pandemic impacted the global antinuclear antibody test market negatively since the majority of people were getting these tests to monitor their health and evaluate their risk for autoimmune illnesses during the crisis.
- Increasing frequency of chronic diseases and rising elderly population are the major causes behind the market expansion.
Key Findings of the Study
- Based on product, the reagents & assay kits sub-segment emerged as the global leader in 2021 and is anticipated to be the fastest growing sub-segment during the forecast period.
- Based on technique, the ELISA sub-segment emerged as the global leader in 2021 and is predicted to show the fastest growth in the upcoming years.
- Based on application, the rheumatoid arthritis sub-segment emerged as the global leader in 2021 and is predicted to show the fastest growth in the upcoming years.
- Based on end-use industry, the hospital sub-segment emerged as the global leader in 2021 and physician office laboratories sub-segment is predicted to show the fastest growth in the upcoming years.
- Based on region, the North America market registered the highest market share in 2021 and is projected to maintain the position during the forecast period.
Ask to Our Industry Expert: https://www.alliedmarketresearch.com/request-for-customization/4259?reqfor=covid
The Reagents & Assay Kits segment to dominate by 2031-
By product, the reagents & assay kits segment contributed to around three-fifths of the global antinuclear antibody test market share in 2021, and is expected to lead the trail by 2031. The same segment would also garner the fastest CAGR of 15.53% during the forecast period. Rise in the use of these kits for various research and development purposes for a better understanding of various types of diseases drives the segment growth.
Key players in the industry-
- Bio-Rad Laboratories, Inc.
- Erba Diagnostics
- Thermo Fisher Scientific
- Antibodies Incorporated
- Trinity Biotech Plc.
- Immuno Concepts NA Ltd.
- ZEUS Scientific, Inc.
- Inova Diagnostics, Inc.
- EUROIMMUN Medizinische Labordiagnostika AG
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.